PYC Therapeutics Secures US FDA's Rare Pediatric Disease Designation for Eye Disease Medication; Shares Hit 52-Week High
PYC Therapeutics Secures US FDA's Rare Pediatric Disease Designation for Eye Disease Medication; Shares Hit 52-Week High
PYC Therapeutics为眼科药物获得美国FDA的罕见儿科疾病认可;股价创下52周高点
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册